Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,867 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission.
García-Gasalla M, Ferrer JM, Fraile-Ribot PA, Ferre-Beltrán A, Rodríguez A, Martínez-Pomar N, Ramon-Clar L, Iglesias A, Losada-López I, Fanjul F, Pou JA, Llompart-Alabern I, Toledo N, Pons J, Oliver A, Riera M, Murillas J. García-Gasalla M, et al. Among authors: oliver a. Can J Infect Dis Med Microbiol. 2021 Aug 2;2021:9965850. doi: 10.1155/2021/9965850. eCollection 2021. Can J Infect Dis Med Microbiol. 2021. PMID: 34422145 Free PMC article.
In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa.
Fraile-Ribot PA, Mulet X, Cabot G, Del Barrio-Tofiño E, Juan C, Pérez JL, Oliver A. Fraile-Ribot PA, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2017 Aug 24;61(9):e01117-17. doi: 10.1128/AAC.01117-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28674059 Free PMC article.
Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands.
Díaz-Cañestro M, Periañez L, Mulet X, Martin-Pena ML, Fraile-Ribot PA, Ayestarán I, Colomar A, Nuñez B, Maciá M, Novo A, Torres V, Asensio J, López-Causapé C, Delgado O, Pérez JL, Murillas J, Riera M, Oliver A. Díaz-Cañestro M, et al. Among authors: oliver a. Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2191-2200. doi: 10.1007/s10096-018-3361-0. Epub 2018 Aug 23. Eur J Clin Microbiol Infect Dis. 2018. PMID: 30141088
Emergence of Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations Due to Horizontally Acquired AmpC (FOX-4) in Pseudomonas aeruginosa Sequence Type 308.
Fraile-Ribot PA, Del Rosario-Quintana C, López-Causapé C, Gomis-Font MA, Ojeda-Vargas M, Oliver A. Fraile-Ribot PA, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e02112-19. doi: 10.1128/AAC.02112-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31685471 Free PMC article. No abstract available.
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants.
Fraile-Ribot PA, Zamorano L, Orellana R, Del Barrio-Tofiño E, Sánchez-Diener I, Cortes-Lara S, López-Causapé C, Cabot G, Bou G, Martínez-Martínez L, Oliver A; GEMARA-SEIMC/REIPI Pseudomonas Study Group. Fraile-Ribot PA, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e02165-19. doi: 10.1128/AAC.02165-19. Print 2020 Jan 27. Antimicrob Agents Chemother. 2020. PMID: 31740559 Free PMC article.
Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy.
Fernández-Esgueva M, López-Calleja AI, Mulet X, Fraile-Ribot PA, Cabot G, Huarte R, Rezusta A, Oliver A. Fernández-Esgueva M, et al. Among authors: oliver a. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Dec;38(10):474-478. doi: 10.1016/j.eimc.2020.01.017. Epub 2020 Mar 3. Enferm Infecc Microbiol Clin (Engl Ed). 2020. PMID: 32143893 English, Spanish.
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection.
Arca-Suárez J, Vázquez-Ucha JC, Fraile-Ribot PA, Lence E, Cabot G, Martínez-Guitián M, Lasarte-Monterrubio C, Rodríguez-Iglesias M, Beceiro A, González-Bello C, Galán-Sánchez F, Oliver A, Bou G. Arca-Suárez J, et al. Among authors: oliver a. J Antimicrob Chemother. 2020 Nov 1;75(11):3209-3217. doi: 10.1093/jac/dkaa291. J Antimicrob Chemother. 2020. PMID: 32728723
1,867 results